AssetMark Inc
BLUE

AssetMark Inc’s bluebird bio BLUE Stock Holding History

AssetMark Inc’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed -$1K – 1252
2016
Q3 		$1K Buy
+1
New +$724 ﹤0.01% 1155
2016
Q1 		– Hold
0
– – – 1182
2015
Q4 		– Hold
0
– – – 1371

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

AssetMark Inc's BLUE Position: Q4 2016 in Review

AssetMark Inc sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 1 share — an estimated $1K sold.

AssetMark Inc first reported a position in BLUE in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

  • AssetMark Inc reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
  • AssetMark Inc sold 1 bluebird bio share in Q4 2016, an estimated $1K.
  • AssetMark Inc first reported a position in bluebird bio in Q3 2016 and held it in 1 quarter.
  • AssetMark Inc's bluebird bio position peaked at $1K in Q3 2016.
  • 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on AssetMark Inc's 13F filing for Q4 2016, filed 14 Feb 2017.